iBio, Inc. (IBIO) Balance Sheet
IBIO balance sheet, FY2026
June 30, 2026 · U.S. dollars$99.1M assets = $13.4M liabilities + $85.7M equity
Both columns are drawn to the same scale: what IBIO owns equals what it owes plus shareholders’ equity. Hover a block for its value.
IBIO financial health
Descriptive bands, not a rating. Fiscal FY2026.
IBIO balance sheet trends, FY2017–FY2026
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $36.0MFY2017 | $99.1MFY2026 | +11.9%/yr | |
| Total liabilities | $27.1MFY2017 | $13.4MFY2026 | −7.5%/yr | |
| Shareholders’ equity | $8.9MFY2017 | $85.7MFY2026 | +28.6%/yr | |
| Cash & short-term investments | $8.1MFY2017 | $88.0MFY2026 | +30.4%/yr | |
| Total debt | $25.3MFY2017 | $2.2MFY2026 | −23.8%/yr | |
| Net cash (debt) | −$17.2MFY2017 | $85.8MFY2026 | +$103.0M | |
| Working capital | $6.6MFY2017 | $80.5MFY2026 | +$73.9M | |
| Current ratio | 4.26FY2017 | 7.85FY2026 | +3.59 | |
| Debt / equity | 2.83FY2017 | 0.03FY2026 | −2.81 |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
IBIO assets
IBIO liabilities and equity
IBIO debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
IBIO balance sheet
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & short-term investments | $88.0M | $8.6M | $14.2M | $7.3M | $33.5M | $97.0M | $55.1M | $4.4M | $15.9M | $8.1M |
| Cash & equivalents | $56.4M | $8.6M | $14.2M | $7.3M | $22.7M | $77.4M | $55.1M | $4.4M | $15.9M | $8.1M |
| Short-term investments | $31.6M | $0 | — | $0 | $10.8M | $19.6M | $0 | — | $0 | $0 |
| Receivables | $1.1M | $105,000 | $713,000 | $204,000 | $6.1M | $5.5M | $5.6M | $97,000 | $75,000 | $175,000 |
| Inventory | $0 | $0 | $0 | $21.1M | $3.9M | $27,000 | $798,000 | $1 | $0 | $26,000 |
| Other current assets | $3.1M | $1.0M | $749,000 | $0 | $1.5M | $2.1M | $214,000 | $289,999 | $276,000 | $283,000 |
| Total current assets | $92.2M | $9.7M | $15.7M | $26.3M | $45.1M | $104.6M | $61.7M | $4.8M | $16.3M | $8.6M |
| Property, plant & equipment (net) | $4.8M | $5.3M | $6.4M | $7.6M | $41.8M | $34.7M | $31.3M | $24.4M | $25.2M | $25.6M |
| Goodwill & intangible assets | $1.8M | $6.8M | $5.4M | $5.4M | $4.9M | $952,000 | $1.1M | $1.4M | $1.6M | $1.8M |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $311,000 | $1.3M | $1.3M | $2.0M | $7.7M | $6.7M | $24,000 | $24,000 | $26,000 | $26,000 |
| Total assets | $99.1M | $23.2M | $28.7M | $41.2M | $99.4M | $147.0M | $94.2M | $30.6M | $43.1M | $36.0M |
| Liabilities | ||||||||||
| Accounts payable | $4.4M | $2.2M | $358,000 | $1.8M | $4.3M | $2.3M | $1.8M | $1.0M | $790,000 | $332,000 |
| Short-term debt | $546,000 | $1.3M | $953,000 | $13.6M | $22.3M | $967,000 | $562,000 | $213,000 | $197,000 | $183,000 |
| Deferred revenue | — | $1.2M | $200,000 | $4.2M | $100,000 | $423,000 | $1.8M | $1.3M | $471,000 | $157,000 |
| Total current liabilities | $11.7M | $6.1M | $3.8M | $21.6M | $30.4M | $6.6M | $5.2M | $3.5M | $2.0M | $2.0M |
| Long-term debt | $0 | $0 | $766,000 | $0 | $0 | $0 | $339,000 | $24.7M | $24.9M | $25.1M |
| Lease obligations | $2.2M | $2.7M | $3.5M | $4.1M | $5.6M | $32.1M | $32.3M | $24.7M | $24.9M | $25.3M |
| Other long-term liabilities | $1.7M | $2.2M | $2.8M | $4.2M | $5.5M | $31.8M | $32.0M | $0 | $0 | $0 |
| Total liabilities | $13.4M | $8.3M | $7.4M | $25.8M | $35.9M | $38.4M | $37.6M | $28.1M | $26.9M | $27.1M |
| Shareholders' equity | ||||||||||
| Common stock & paid-in capital | $56,000 | $19,000 | $9,000 | $20,000 | $9,000 | $9,000 | $140,000 | $20,000 | $104.4M | $81.1M |
| Retained earnings (deficit) | −$365.3M | −$332.2M | −$313.8M | −$288.9M | −$223.9M | −$173.6M | −$150.4M | −$105.8M | −$88.2M | −$72.1M |
| Treasury stock | — | — | — | — | — | — | — | — | $0 | $0 |
| Accumulated other comprehensive income | −$45,000 | — | — | — | −$213,000 | −$63,000 | −$33,000 | −$31,000 | −$30,000 | −$29,000 |
| Minority interest | — | — | — | — | — | — | −$11,000 | −$6,000 | −$2,000 | $1,000 |
| Total shareholders' equity | $85.7M | $14.9M | $21.3M | $15.4M | $63.5M | $108.6M | $56.6M | $2.5M | $16.2M | $8.9M |
| Key figures | ||||||||||
| Total debt | $2.2M | $3.5M | $4.5M | $17.1M | $25.8M | $32.7M | $32.9M | $24.9M | $25.1M | $25.3M |
| Net cash (debt) | $85.8M | $5.1M | $9.8M | −$9.7M | $7.8M | $64.3M | $22.2M | −$20.5M | −$9.1M | −$17.2M |
| Working capital | $80.5M | $3.6M | $11.8M | $4.7M | $14.6M | $98.0M | $56.5M | $1.4M | $14.2M | $6.6M |
| Tangible book value | $83.9M | $8.0M | $16.0M | $10.0M | $58.6M | $107.6M | $55.5M | $1.1M | $14.5M | $7.1M |
| Book value per share | $0.82 | — | — | — | — | — | — | — | — | — |
| Shares outstanding | 104.1M | — | — | — | — | — | — | — | — | — |
| Current ratio | 7.85 | 1.59 | 4.08 | 1.22 | 1.48 | 15.74 | 11.79 | 1.39 | 8.00 | 4.26 |
| Quick ratio | 7.59 | 1.42 | 3.89 | 0.35 | 1.30 | 15.43 | 11.60 | 1.31 | 7.87 | 4.10 |
| Debt / equity | 0.03 | 0.24 | 0.21 | 1.11 | 0.41 | 0.30 | 0.58 | 10.10 | 1.55 | 2.83 |
| Equity / assets | 86.5% | 64.2% | 74.2% | 37.3% | 63.9% | 73.9% | 60.1% | 8.1% | 37.5% | 24.8% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $88.0M | $74.8M | $52.7M | $49.6M | $8.6M | $5.0M | $7.0M | $11.0M | $14.2M | $5.3M | $2.8M | $1.5M |
| Cash & equivalents | $56.4M | $47.6M | $28.7M | $28.1M | $8.6M | $5.0M | $7.0M | $11.0M | $14.2M | $5.3M | $2.8M | $1.5M |
| Short-term investments | $31.6M | $27.2M | $24.0M | $21.5M | $0 | — | — | — | — | — | — | — |
| Receivables | $1.1M | $0 | $0 | $65,000 | $105,000 | $0 | $13,000 | $0 | $713,000 | $14.1M | $1.8M | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $14.3M | $0 |
| Other current assets | $3.1M | $2.5M | $670,000 | $1.1M | $1.0M | $1.1M | $1.3M | $667,000 | $749,000 | $16.7M | $894,000 | $21.6M |
| Total current assets | $92.2M | $77.3M | $53.4M | $50.8M | $9.7M | $6.1M | $8.3M | $11.7M | $15.7M | $36.1M | $19.7M | $23.0M |
| Property, plant & equipment (net) | $4.8M | $5.1M | $5.3M | $5.2M | $5.3M | $5.6M | $5.8M | $6.1M | $6.4M | $6.6M | $6.9M | $7.2M |
| Goodwill & intangible assets | $1.8M | $1.8M | $4.3M | $6.8M | $6.8M | $6.1M | $6.1M | $5.4M | $5.4M | $5.4M | $5.4M | $5.4M |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $311,000 | $1.7M | $1.4M | $1.4M | $1.3M | $1.4M | $1.5M | $1.4M | $1.3M | $2.0M | $2.0M | $2.0M |
| Total assets | $99.1M | $85.8M | $64.4M | $64.2M | $23.2M | $19.1M | $21.7M | $24.5M | $28.7M | $50.2M | $34.0M | $37.7M |
| Liabilities | ||||||||||||
| Accounts payable | $4.4M | $3.0M | $2.7M | $2.8M | $2.2M | $1.5M | $614,000 | $855,000 | $358,000 | $1.2M | $1.9M | $1.9M |
| Short-term debt | $546,000 | $532,000 | $518,000 | $1.2M | $1.3M | $1.4M | $904,000 | $955,000 | $953,000 | $13.6M | $14.0M | $13.5M |
| Deferred revenue | — | $1.1M | $1.1M | $1.1M | $1.2M | $600,000 | $600,000 | $400,000 | $200,000 | $175,000 | $4.4M | $3.6M |
| Total current liabilities | $11.7M | $6.5M | $5.9M | $6.0M | $6.1M | $5.4M | $4.7M | $3.5M | $3.8M | $21.4M | $21.6M | $20.7M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $643,000 | $706,000 | $766,000 | $824,000 | $0 | $0 |
| Lease obligations | $2.2M | $2.3M | $2.5M | $2.6M | $2.7M | $2.9M | $3.1M | $3.3M | $3.5M | $3.6M | $3.8M | $4.0M |
| Other long-term liabilities | $1.7M | $1.8M | $1.9M | $2.1M | $2.2M | $2.3M | $2.5M | $2.6M | $2.8M | $3.0M | $3.3M | $3.8M |
| Total liabilities | $13.4M | $8.3M | $7.8M | $8.1M | $8.3M | $7.7M | $7.8M | $6.8M | $7.4M | $25.3M | $24.8M | $24.5M |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $56,000 | $35,000 | $30,000 | $20,000 | $19,000 | $10,000 | $9,000 | $9,000 | $9,000 | $9,000 | $30,000 | $28,000 |
| Retained earnings (deficit) | −$365.3M | −$354.7M | −$346.9M | −$337.9M | −$332.2M | −$327.1M | −$322.2M | −$317.8M | −$313.8M | −$306.1M | −$302.9M | −$294.7M |
| Accumulated other comprehensive income | −$45,000 | −$21,000 | $10,000 | −$15,000 | — | — | — | — | — | — | $0 | $0 |
| Total shareholders' equity | $85.7M | $77.5M | $56.6M | $56.0M | $14.9M | $11.4M | $13.9M | $17.8M | $21.3M | $24.9M | $9.2M | $13.2M |
| Key figures | ||||||||||||
| Total debt | $2.2M | $2.3M | $2.5M | $3.3M | $3.5M | $3.8M | $4.0M | $4.2M | $4.5M | $17.3M | $17.3M | $17.0M |
| Net cash (debt) | $85.8M | $72.5M | $50.2M | $46.3M | $5.1M | $1.2M | $3.0M | $6.8M | $9.8M | −$12.0M | −$14.5M | −$15.5M |
| Working capital | $80.5M | $70.7M | $47.5M | $44.7M | $3.6M | $663,000 | $3.6M | $8.2M | $11.8M | $14.7M | −$1.9M | $2.3M |
| Tangible book value | $83.9M | $75.7M | $52.2M | $49.2M | $8.0M | $5.3M | $7.8M | $12.4M | $16.0M | $19.5M | $3.8M | $7.8M |
| Book value per share | $0.82 | $0.65 | $0.57 | $1.06 | $0.91 | — | — | — | — | — | — | — |
| Shares outstanding | 104.1M | 119.6M | 99.1M | 53.0M | 16.4M | — | — | — | — | — | — | — |
| Current ratio | 7.85 | 11.88 | 9.04 | 8.39 | 1.59 | 1.12 | 1.76 | 3.37 | 4.08 | 1.69 | 0.91 | 1.11 |
| Quick ratio | 7.59 | 11.50 | 8.93 | 8.21 | 1.42 | 0.92 | 1.49 | 3.18 | 3.89 | 0.91 | 0.21 | 0.07 |
| Debt / equity | 0.03 | 0.03 | 0.04 | 0.06 | 0.24 | 0.33 | 0.29 | 0.24 | 0.21 | 0.70 | 1.88 | 1.28 |
| Equity / assets | 86.5% | 90.3% | 87.8% | 87.3% | 64.2% | 59.6% | 64.0% | 72.4% | 74.2% | 49.6% | 27.0% | 35.1% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed August 28, 2026); data from EODHD.
IBIO financial position
At the end of fiscal 2026 (June 30, 2026), iBio had total assets of $99.1 million (up 327.5% from a year earlier), total liabilities of $13.4 million and shareholders' equity of $85.7 million. It held $88.0 million in cash and short-term investments against $2.2 million of debt, a net cash position of $85.8 million. Its current ratio was 7.85.
Related: IBIO income statement, IBIO cash flow statement, IBIO key metrics. See the IBIO stock overview for the latest quote and news.
IBIO balance sheet FAQ
What are iBio's total assets?
iBio reported total assets of $99.1 million at the end of fiscal 2026 (June 30, 2026), compared with $23.2 million a year earlier.
How much debt does iBio have?
iBio had $2.2 million of total debt at the end of fiscal 2026, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.03.
How much cash does iBio have?
iBio held $88.0 million in cash and short-term investments at the end of fiscal 2026; with $2.2 million of debt that is net cash of $85.8 million.
What is iBio's book value?
iBio's shareholders' equity (book value) was $85.7 million at the end of fiscal 2026, or $0.82 per share.
What is iBio's current ratio?
iBio had current assets of $92.2 million and current liabilities of $11.7 million, a current ratio of 7.85 (it can cover its short-term obligations).
How much goodwill does iBio have?
iBio carried $1.8 million of goodwill and intangible assets, 1.8% of total assets, at the end of fiscal 2026.